DUBLIN–(BUSINESS WIRE)–Research and Markets has announced the addition of the “Optic Neuropathy – Pipeline Review, H1 2016” report to their offering. This report provides comprehensive information on the therapeutic development for Optic Neuropathy, …
MS vision loss could be helped by OTC drug
Vision damage in people with MS has been partially reversed by an over-the-counter drug used to treat allergies. Results of the study are being presented at AAN’s annual meeting.
Cell and Gene Therapy Catapult, UCLB and Imperial Innovations announce positive interim review in ongoing AML WT1 T cell clinical trial
Hundreds of thousands of people worldwide, who have a disease that can lead to blindness, could have their sight restored after The University of Manchester entered into a technology license with Seattle-based company Acucela Inc.
University’s blindness therapy comes a step closer following landmark licensing deal with US firm
Hundreds of thousands of people worldwide, who have a disease that can lead to blindness, could have their sight restored after The University of Manchester entered into a technology license with Seattle-based company Acucela Inc.
Uncategorized
Surgical success rate similar between two- and three-muscle approaches to correct large-angle esotropia
VANCOUVER, British Columbia — Mediocre long-term outcomes were achieved after single surgery with either a uniform two-muscle approach or a selective three- to four-muscle approach in cases of large-angle esotropia in children, according to a study presented here. “The first thing to note is the relatively low surgical success rate [approximately 30%] regardless of the surgery used, and this despite our relatively liberal definition of success,” Matthew C. Weed, MD, said at the American Association for Pediatric Ophthalmology and Strabismus meeting.
Uncategorized
Antihistamine may reverse vision damage associated with multiple sclerosis
An OTC antihistamine reversed chronic vision damage in patients with multiple sclerosis, according to a preliminary study released ahead of the American Academy of Neurology meeting. Ari Green, MD, of the Multiple Sclerosis Center at the Universit…